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Abstract
Background: The Drosophila SXL protein controls sex determination and dosage compensation. It is a sex-specific factor
controlling splicing of its own Sxl pre-mRNA (auto-regulation), tra pre-mRNA (sex determination) and msl-2 pre-mRNA plus
translation of msl-2 mRNA (dosage compensation). Outside the drosophilids, the same SXL protein has been found in both
sexes so that, in the non-drosophilids, SXL does not appear to play the key discriminating role in sex determination and
dosage compensation that it plays in Drosophila. Comparison of SXL proteins revealed that its spatial organisation is
conserved, with the RNA-binding domains being highly conserved, whereas the N- and C-terminal domains showing
significant variation. This manuscript focuses on the evolution of the SXL protein itself and not on regulation of its
expression.
Methodology: Drosophila-Sciara chimeric SXL proteins were produced. Sciara SXL represents the non-sex-specific function
of ancient SXL in the non-drosophilids from which presumably Drosophila SXL evolved. Two questions were addressed. Did
the Drosophila SXL protein have affected their functions when their N- and C-terminal domains were replaced by the
corresponding ones of Sciara? Did the Sciara SXL protein acquire Drosophila sex-specific functions when the Drosophila N-
and C-terminal domains replaced those of Sciara? The chimeric SXL proteins were analysed in vitro to study their binding
affinity and cooperative properties, and in vivo to analyse their effect on sex determination and dosage compensation by
producing Drosophila flies that were transgenic for the chimeric SXL proteins.
Conclusions: The sex-specific properties of extant Drosophila SXL protein depend on its global structure rather than on a
specific domain. This implies that the modifications, mainly in the N- and C-terminal domains, that occurred in the SXL
protein during its evolution within the drosophilid lineage represent co-evolutionary changes that determine the
appropriate folding of SXL to carry out its sex-specific functions.
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Introduction
In Drosophila melanogaster, the gene Sex-lethal (Sxl) controls both
sex determination and dosage compensation (reviewed in [1]) (see
Figure 1). The functional state of Sxl becomes fixed at blastoderm
stage so that Sxl is activated in females but not in males [2,3]. The
capacity of Sxl to maintain its functional state throughout
development and during the adult life of females is owed to its
auto-regulatory function [4], manifested by the requirement of the
SXL protein for the female-specific splicing of its own primary
transcript [5]. SXL controls sex determination by regulating the
female-specific splicing of the primary transcript from gene
transformer (tra), so that only in females functional TRA protein is
produced [6–10]. In D. melanogaster, dosage compensation is
achieved in males by hyper-transcription of the single X
chromosome and is controlled by the msl’s genes, whose products
form the MSL complex that binds to the X chromosome (reviewed
in [11,12]). MSL is only formed in males because the presence of
SXL protein in females prevents the production of protein MSL2
and consequently the formation of MSL. Thus, SXL controls
dosage compensation by regulating the expression of gene msl2.
This regulation takes place at the splicing and translational levels
[13–16]. Sxl is also involved in the sexual development of the germ
line (reviewed in [17]), yet the work presented here is focused on
the soma and not on the germ line.
The SXL protein is a member of the RNA binding family of
proteins. The analyses in vitro and in vivo of different Drosophila
SXL-truncated protein constructs have determined that Drosophila
SXL contains three well-defined domains: the central region
formed by two RNA-binding domains, RBD1 and RBD2
(separated by a linker region), which endow to SXL with the
capacity to bind to target sequences present in the Sxl, tra and msl-2
pre-mRNAs; the amino-terminal domain that is involved in co-
operation; and the carboxyl-terminal domain to which no specific
function has been assigned, although it has been suggested that this
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domain might give structural stability to the protein [18].
Notwithstanding, conflicting results have been reported regarding
the contribution of the SXL domains required for protein-protein
interaction and, consequently, the co-operative binding of SXL. It
has been claimed that the N-terminal region of SXL protein is
involved in protein-protein interactions (SXL multimerisation) and
is absolutely required for proper control of Sxl pre-mRNA
alternative splicing [19–21]. According to Samuels et al. [22],
however, protein-protein interaction is mediated by the RBDs
domains, not by the amino terminal region, and can occur in the
absence of additional, exogenous RNA. Sakashita and Sakamoto
[23] have also reached the same conclusion concerning the
importance of RBDs for SXL-SXL interaction but, in contrast to
Samuels et al. [24] and in agreement with Wang and Bell [20],
have claimed that homo-dimerization of SXL is RNA dependent.
There is also some controversy concerning the function of the N-
terminal domain of SXL in tra pre-mRNA sex-specific splicing
regulation. It has been proposed that this region is not necessary
for tra pre-mRNA splicing regulation [25], while others have
proposed the opposite [10]. With respect to the control of dosage
compensation by SXL protein, it has been reported that the N-
terminal domain is not required for preventing msl-2 expression
[10,26]. The two SXL RBD domains by themselves are able to
control in vitro msl-2 mRNA translation [26]. These contradictory
results might be due to the different methodologies as well as the
different SXL protein constructs used by the authors.
Deletions of the amino and the carboxyl termini do not interfere
with the ability of SXL RBDs to properly bind in vitro to their
target sequences. Nevertheless, both RNA binding domains in cis
are required for site-specific RNA binding [20,21,24,27]. The
Figure 1. Scheme showing the sex-specific functions of the Drosophila SXL protein. Normal and dashed lines indicate active and inactive
interactions, respectively. The crossed boxes for SXL, TRA and MSL-2 proteins designate lack of these proteins. After blastoderm stage, Sxl begins to
function in both sexes, and production of the Sxl transcripts persist throughout the remainder of development and adult life. The male-specific
transcripts are similar to their female-specific counterparts, except for the presence of an additional exon (exon 3), which contains translational stop
codons. Consequently, male transcripts give rise to presumably inactive truncated proteins. In females, this exon 3 is spliced out and functional SXL
protein is produced [67,68]. The gene tra is transcribed in both sexes but its pre-mRNA follows an alternative splicing. In males, exon 2 introduces a
translational stop codon, leading to the production of a truncated, presumably non-functional TRA protein. In females, however, approximately half
of the tra pre-mRNA is spliced differently due to the intervention of the SXL protein, so that the RNA fragment on exon 2 containing the translation
stop codon is not incorporated into the mature mRNA encoding the whole, functional TRA protein [6–10]. The gene msl-2 is transcribed in both sexes
but its pre-mRNA follows an alternative splicing. In females, the SXL protein prevents the splicing of an exon at the 59 UTR, which introduces SXL-
binding sequences [13–16]. Consequently, SXL binds to these sequences and to those located at the 39UTR inhibiting the translation of the msl2-
mRNA and then MSL2 protein is not synthesised [69,70]. In males, however, the exon at the 59 UTR is spliced out and MSL2 protein is produced.
doi:10.1371/journal.pone.0065171.g001
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properties of several SXL protein constructs have been tested
in vitro for their binding capacity [24]. Either RBD1 or RBD2
alone show reduced RNA binding activities. Duplications of the
RBDs (RBD1-RBD1 and RBD2-RBD2) do not affect the RNA
binding capacity but interfere with RNA recognition properties.
Proteins in which the order of the two RBDs has been reversed
(RBD2-RBD1) bind very weakly to oligonucleotides that contain
only a single SXL-binding site. Nevertheless, the binding is close to
normal if an oligonucleotide containing two binding sites is used as
a probe, reflecting possible reestablishment of protein-protein
interactions.
The Sxl gene has been characterised in different Drosophila
species, D. virilis [28] and D. subobscura [29]. As in D. melanogaster,
Sxl regulation occurs by female-specific alternative splicing.
Outside the genus Drosophila, Sxl has been characterised in the
dipterans Chrysomya rufifacies (blowfly) [30], Megaselia scalaris (the
phorid fly) [31,32] and Musca domestica (the housefly) [33], in the
tephritids Ceratitis capitata (Medfly) [34] and Bactrocera oleae (olive fly)
[35] (all of which belong to the suborder Brachycera), and in Sciara
ocellaris [36], Sciara coprophila, Rynchosciara americana and Trichosia
pubescens [37], which belong to the suborder Nematocera. Sxl has
been also characterised in the lepidopteron Bombyx mori [38]. The
Sxl gene of all these species is not regulated in a sex-specific
manner, and therefore the same Sxl transcript encoding the
functional SXL protein is found in both males and females. Thus,
in the non-drosophilids, Sxl does not appear to play the key
discriminating role in sex determination that it plays in Drosophila,
but it seems to have a non-sex-specific function. Furthermore, in
Sciara, where males are X0;2A and females are 2X;2A (reviewed in
[39,40]) and dosage compensation appears to be achieved by
hypertranscription of the single X chromosome in males [41]
2although different proteins seem to implement dosage compen-
sation in Drosophila and Sciara [42]2 the SXL protein has been
found in polytene chromosomal regions of all actively transcribing
chromosomes, co-localising with RNA polymerase II 2as
expected for a general splicing factor2 but not with RNA
polymerase I. This has been observed in both sexes in S. ocellaris
[36], and in S. coprophila, R. americana and T. pubescens [37]. These
results agree with the proposition that the non-drosophilist SXL
protein might be involved in general non-sex specific gene
regulation at the splicing and/or translational levels that would
correspond to its ancestral non-sex specific function.
This manuscript focuses on the evolution of the SXL protein
itself and not on the regulation of its expression. It is common that
the arising of proteins with new functions being preceded by
duplication of the gene encoding the original protein, followed by
modification of one of the duplicated copies. The SXL protein is
an example [43,44]. The question naturally arises regarding which
of the features present in the extant Drosophila protein have profited
from the ancestral SXL protein and which ones have evolved
during the phylogenetic lineage that gave rise to the drosophilids.
The work here presented tries to address this question. To this
respect, chimeric proteins between the SXL proteins of D.
melanogaster and S. ocellaris were generated and their function tested
on D. melanogaster sex determination and dosage compensation.
Results
Binding of the Drosophila-Sciara Chimeric SXL Proteins to
Drosophila SXL-Binding Sites
The binding strength of both Drosophila (RBDs-mel) and Sciara
(RBDs-sci) RNA-binding domains without the N- and C-terminal
domains to SXL-binding poly(U) sequences was similar: Kd for
Drosophila-RBDs was 350650 mM and Kd for Sciara-RBDs was
340640 mM (6 refers to 95% confidence interval; t-test: P
value = 0,27; P.0,5). Four mel-sci chimeric SXL proteins were
then constructed by interchanging the N- and C-terminal domains
of Drosophila and Sciara SXL proteins: chimera SX17 corresponds
to the Drosophila SXL protein with the N-terminal domain of Sciara
SXL; chimera SX64 corresponds to the Drosophila SXL protein
with the C-terminal domain of Sciara SXL; chimera SX35
corresponds to the Sciara SXL protein with the N-terminal domain
of Drosophila SXL and chimera SX28 corresponds to the Sciara
SXL protein with the C-terminal domain of Drosophila SXL. As
control, we used the normal Drosophila (SXM) and Sciara (SXS)
SXL proteins. In all cases, they corresponded to full-length
proteins.
The binding capacity of these chimeric proteins (GST-SXL
fusion constructs) to SXL-binding poly(U) sequences was checked
by in vitro RNA-binding assays (EMSA) using as substrate an RNA
fragment containing a single copy of the poly(U) sequence located
upstream and adjacent to the male-specific exon of Drosophila Sxl.
Three replicas for each SXL protein were performed (for details
see Material and Methods). The binding of the GST-SXL fusion
proteins was due to SXL and not to GST since this by itself did not
show binding to the poly(U)sequence, and secondly the binding
was specific as the GST-SXL proteins did not bind to a non-
poly(U) sequence (data not shown). The results are presented in
Table 1. The Drosophila SXL protein (SXM) showed a binding
ability significantly higher than that of Sciara (SXS) (t-test: P
value = 8,216; 0,002,P,0,001). The binding capacity of the
Drosophila SXL protein decreased when that of Sciara replaces its
N-terminal domain (chimera SX17) (t-test: P value = 6,432;
0,005,P,0,002) or its C-terminal domain (chimera SX64)
though in this latter case it was not significant (t-test: P
value = 1,829; 0,2,P,0,1) (but see below). The binding capacity
of the Sciara SXL protein improved when that of Drosophila
replaces either its N-terminal domain (chimera SX35) (t-test: P
value = 5,284; 0,01,P,0,005) or its C-terminal domain (chimera
SX28) (t-test: P value = 5,952; 0,005,P,0,002) although this
improvement did not reach the capacity shown by the own
Drosophila SXL protein (SXM).
The N-terminal domain of Drosophila SXL protein is involved in
the co-operative binding of SXL to RNAs containing two or more
poly(U) sequences [20,27]. To test the co-operative capacity of the
chimeric SXL proteins, RNA-binding analyses were performed by
using as substrate an RNA fragment containing two poly(U)
sequences located in intron 2 of Drosophila Sxl pre-mRNA, which
have been shown to bind SXL in a co-operative manner [20].
Three replicas for each SXL protein were performed (for details
see Material and Methods). The results are shown in Table 1 and
Figure 2. The binding capacity of the normal Drosophila and Sciara
SXL proteins, as well as of all chimeric proteins, significantly
increased, as expected by the presence of two RNA target
sequences in tandem. No significant differences were observed in
this scenario for the normal Drosophila and Sciara SXL proteins (t-
test: P value = 0,966; 0,5.P.0,2), but a significant reduction was
observed for the Drosophila SXL protein (SXM) when its amino
terminal (chimera SX17) (t-test: P value = 5,654; 0,005,P,0,002)
or its carboxyl terminal (chimera SX64) (t-test: P value = 6,25;
0,005,P,0,002) regions were replaced by the corresponding ones
of Sciara. A reduction was also observed for the Sciara SXL protein
(SXS) when the amino (chimera SX35) (t-test: P value = 2,316;
0,05,P,0,1) or carboxyl (chimera SX28) (t-test: P value = 11,326;
P,0,001) terminal domains were replaced by the corresponding
Drosophila domains, with a highly significant binding reduction for
SX28. Most importantly, whereas the binding of Drosophila SXL
protein (SXM) was cooperative (Hill n.2), the binding of the
Molecular Evolution of the Sex-Lethal Protein
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Sciara SXL protein (SXS) and the four chimeric SXL proteins was
best described with an independent binding site scheme, without
co-operation (Hill n = 1).
Collectively, these results agree with the idea that both the
binding strength and the co-operation of the normal and chimeric
SXL proteins are not given by a specific domain of the protein but
it depends on the whole protein.
The EMSA’s showed that the Sciara SXL protein formed
aggregates that remained in the wells of the gel, not entering into
the lane, in contrast to the behaviour shown by the Drosophila SXL
protein. This latter protein, however, formed aggregates when its
C-terminal domain was replaced by that of Sciara (chimera SX64),
whereas the Sciara SXL protein lost this aggregation capacity when
that of Drosophila replaced its C-terminal domain (chimera SX28)
(Figure S1). This aggregation capacity was also observed for the
chimera SX35 but not for the chimera SX17; the first carried the
C-terminal domain of Sciara SXL whereas the second contained
the C-terminal domain of Drosophila SXL. Thus, it seems that the
C-terminal domain of Sciara SXL exhibits aggregation capacity.
This feature was fundamentally dependent on the presence of
poly(U) ligand since by itself the Sciara SXL protein did show a
very low aggregation capacity (Figure S2). How much this
aggregation property affects the binding capacity as well as the
co-operative ability of the SXL proteins remains to be determined.
Effect of the Drosophila-Sciara Chimeric SXL Proteins in
Drosophila
To test the function in vivo of the Drosophila-Sciara chimeric and
the normal SXL proteins of D. melanogaster and S. ocellaris, as
control, the corresponding ORFs were linked to UAS sequences
and transgenic D. melanogaster flies were generated. To express the
transgenic SXL proteins, the Arm-GAL4 driver line, which drives
expression ubiquitously, was used. As expected, none of the
transgenic D. melanogaster lines expressed the corresponding
transgene in the absence of GAL4. If any basal expression existed,
this would be irrelevant since XX and XY flies were normal, fertile
females and males respectively. The effect of the transgenes was
analysed by monitoring the viability of males since the expression
of the SXL protein in males impairs the dosage compensation
process what causes their lethality (see Introduction and Figure 1).
Thus, the male-specific lethality was used as criterion for the Sxl-
function of chimeric SXL proteins. In addition, since the D.
melanogaster males do not express the full, female-specific functional
SXL protein, this allowed us to test the direct effect of the SXL
transgenes without interference of the wild type endogenous Sxl
copy present in females (see below).
The four transgenic lines for the Drosophila SXL protein (Sxm
transgene) caused full lethality to males. The six transgenic lines
for the Sciara SXL protein (Sxs transgene) did not affect male
viability. The four transgenic lines for the chimeric SX17 protein
(Sx17 transgene) caused full lethality to males. Among the five
transgenic lines for the chimeric SX64 protein (Sx64 transgene)
four of them showed differently male lethality that ranges from 82
to 95%, whereas the remaining line did not affect male viability.
The five transgenic lines for the chimeric SX35 protein (Sx35
transgene) showed different effect on male lethality that ranges
from 21 to 98%. Finally, among the four transgenic lines for the
chimeric SX28 protein (Sx28 transgene) only one line caused a
minor male lethality (13%) whereas the rest of the lines did not
affect male viability. The different effect of the same transgene is
likely due to its different expression caused by the distinct
chromosome location where the transgene was inserted. None of
the transgenic lines affected females. Therefore, for functional
analysis we selected the transgenic line showing the strongest male-
specific lethality as the representative of each corresponding
chimeric SXL protein.
The effect of the transgenes was analysed in males carrying the
normal endogenous Sxl+ allele on its X chromosome. It has been
shown that transient expression of the Drosophila SXL protein in
normal XY males causes the establishment of the auto-regulatory
function of the endogenous Sxl+ copy [5]. Therefore, the effect of
the Sxl transgenes on male viability described above could be due
to its effect on the endogenous Sxl+ allele; that is, the transgenic
SXL protein imposed to the endogenous Sxl+ pre-mRNA the
female-mode of splicing so that endogenous normal, functional
SXL protein was produced resulting in the establishment of the
auto-regulatory function of the endogenous Sxl+ copy, and
consequently in the permanent production of normal female
SXL protein causing the male lethality. To circumvent this
problem and to test the direct effect of the chimeric SXL proteins
on male viability, these proteins were expressed in males carrying a
null endogenous Sxl allele that does not produce functional SXL
protein. The results of this analysis are presented in Table 2 (for
details see Footnote to this Table).
The Drosophila SXL protein (SXM) caused full lethality to males
either with or without an endogenous Sxl+ allele, as expected since
this gene controls dosage compensation (see Figure 1). The
replacement of its N- or C-terminal domains by those of Sciara
appeared to impair male viability albeit with different degree that
depends on the status of the endogenous Sxl copy. The substitution
of the N-terminal domain (chimeric SX17 protein) produced full
lethality that was practically suppressed (0,9% lethality) when the
endogenous Sxl+ allele was substituted by a null allele. This
Table 1. Binding of the chimeric SXL proteins to Drosophila SXL-binding sequences.
SXL protein N-terminal domain RBD domains C-terminal domain
Kd (mM) for single SXL-
binding site
Kd (mM) for double SXL-
binding site
SXM Drosophila Drosophila Drosophila 150620 0,560,3
SXS Sciara Sciara Sciara 450660 0,360,2
SX17 Sciara Drosophila Drosophila 350650 2,460,5
SX64 Drosophila Drosophila Sciara 180620 2,360,4
SX35 Drosophila Sciara Sciara 230640 0,960,4
SX28 Sciara Sciara Drosophila 230650 3,860,5
It is indicated the origin of the different domains that compose the SXL proteins. ‘‘Drosophila’’ stands for Drosophila melanogaster y ‘‘Sciara’’ stands for Sciara ocellaris.6
refers to 95% confidence interval.
doi:10.1371/journal.pone.0065171.t001
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suggests that the male lethality is not a direct effect of this chimeric
protein, which seems not to affect by itself dosage compensation,
but an indirect effect through the endogenous Sxl+ allele: the SX17
protein would set up the auto-regulation of endogenous Sxl+ copy
by imposing the female-specific splicing to its Sxl pre-mRNA. The
replacement of the C-terminal domain (chimeric SX64 protein)
produced a severe male lethality (95%) that was partially
suppressed (60% lethality) when the endogenous Sxl+ allele was
substituted by a null allele. This suggests that this chimeric protein
by itself can to a certain extent disturb male viability by damaging
the dosage compensation process. The increase in lethality when
the males contain an Sxl+ allele further implies that SX64 seems to
affect also Sxl pre-mRNA splicing regulation so that it is capable of
establishing the auto-regulation of the endogenous Sxl+ allele.
The Sciara SXL protein (SXS) and essentially the chimeric
SX28 protein (the Sciara protein with the C-terminal domain of
Drosophila) did not practically affect the viability of males either
with or without an endogenous Sxl+ allele. This suggests that these
proteins are not capable of establishing the auto-regulatory
function of the endogenous Sxl+ copy and that by themselves do
not seem to affect dosage compensation. Nevertheless, the
replacement of its N- or C-terminal domains by those of Drosophila
appeared to impair male viability albeit with different degree. The
substitution of the N-terminal domain (chimeric SX35 protein)
produced a severe male lethality (98%) that was slightly reduced
(87% lethality) when the endogenous Sxl+ allele was substituted by
a null allele. This suggests that this chimeric protein by itself
disturbs male viability via damaging the dosage compensation
process, and furthermore it makes possible the auto-regulation of
the endogenous Sxl+ allele acting on the splicing regulation of its
primary transcript.
In all the cases, the viability of transgenic females was not
affected whether they carried one or two doses of the endogenous
Sxl+ allele (data not shown). Moreover, in all cases, the transgenic
males that survived showed normal male external morphology. In
addition, none of them showed the female- but the male-specific
splicing of tra pre-mRNA (data not shown). This does not imply
necessarily that the transgenic SXL proteins do not have a putative
effect on sex determination. It could be attributed to the fact that
because SXL controls dosage compensation, the males that
survived are those in which the production of transgenic SXL
protein was not sufficient to damage the dosage compensation
process and then to affect their sexual development. To
circumvent this problem, the HS-GAL4 driver was used and the
cultures were subjected to a daily heat-shock regime at 37uC for 1
hour throughout development. We were trying to see if the
amount of produced chimeric SXL protein was insufficient to
affect male viability but sufficient to impose the female sexual
development. This protocol did not affect the viability of any of the
transgenic males, which showed a normal male morphology (data
not shown), suggesting that the heat-shock treatment did not
induce sufficient amount of transgenic SXL protein to compromise
both sex determination and dosage compensation.
To get around these difficulties, the function of the chimeric
SXL proteins was directly tested on the splicing regulation of Sxl,
tra and msl-2 primary transcripts (see Figure 1). The rationale of
these studies is to prevent lethality of the transgenic males so that
they can reach the adulthood, and then to express the transgenic
SXL proteins. For this purpose the GAL4/GAL80 system was used.
The GAL80 protein inhibits GAL4 protein function. GAL80 is
temperature sensitive, with 18uC the most permissive temperature
and 30uC the most restrictive [45]. XY males carrying a null Sxl
allele, the corresponding transgenic SXL protein (UAS::Sxl-
transgene), the Tub-Gal4 driver and Tub-Gal80 were produced by
allowing them to develop at 18uC. This was possible because the
GAL80 protein inhibited the function of the GAL4 protein so that
no transgenic SXL protein was synthesised. The transgenic adult
males were collected and transferred to 30uC during three days to
allow the production of transgenic protein since GAL80 was not
now functional and the GAL4 protein activated the UAS::Sxl-
transgene. The direct effect of the transgenic SXL proteins was
assured because the males carried a null Sxl allele that gives rise to
primary transcript but no protein. The results are shown in
Figure 3 (for details see Materials and Methods, and legend to this
Figure).
As expected, the Drosophila SXL protein (SXM) induced the
female-specific splicing of the endogenous Sxl pre-mRNA as
revealed by the small band in lane SXM (Figure 3A). The same
band appeared in lanes SX17 and SX64 indicating that the
replacement in the Drosophila SXL protein of its N-terminal
(chimera SX17) or C-terminal (chimera SX64) domains by those
of Sciara did not affect the capacity of these chimeric proteins to
impose the auto-regulatory function to the endogenous Sxl+ copy.
The band corresponding to SX64 was slightly less intense than
that of SX17, which was similar to the own transgenic Drosophila
SXL protein (SXM), in agreement with the full and non-fully
lethality caused by SX17 and SX64, respectively, to Sxl+/Y males
(Table 2). On the contrary, the Sciara SXL protein (SXS) had no
effect on the splicing of the endogenous Sxl pre-mRNA since the
small band corresponding to the female-specific splicing did not
appear (lane SXS), indicating that this protein cannot establish the
auto-regulatory function of the endogenous Sxl+ copy, in
agreement with the viability of Sxl+/Y males expressing SXS
(Table 2). Nevertheless, this function was partially recovered if the
N-terminal domain of Drosophila replaced that of Sciara (lane SX35)
but not if the C-terminal domain was the substituted one (lane
SX28). This is consistent with the partial recovery of males lacking
the endogenous Sxl+ copy and expressing the chimera SX35, and
the minor effect of chimera SX28 on viability of Sxl+/Y males. For
all transgenes, PCR reactions with RNA samples were performed
to guarantee there was no contamination with genomic DNA
(negative controls of PCR reactions).
Figure 3B shows the results of transgenic SXL proteins on sex
determination through their effect on the splicing regulation of
endogenous tra pre-mRNA. Whereas the effect of the transgenic
proteins on Sxl pre-mRNA splicing was already detected after the
first PCR following the RT reaction, their effect on tra pre-mRNA
splicing failed to detect any amplification corresponding to the
female-specific mRNA isoform; only the band (401 bp) corre-
sponding to the non-sex specific mRNA isoform was amplified
(data not shown). It has been reported a delay in the effect of
transgenic Drosophila SXL protein on the splicing pattern of tra pre-
mRNA in males with an endogenous Sxl+ copy, and even a failure
to detect the female-spliced tra mRNA isoform when the
expression of the normal SXL protein was transiently induced in
males lacking the endogenous Sxl+ copy [5]. Hence, we performed
Figure 2. Biochemical characterization of SXL proteins. Quantitative analysis of the EMSA’s (an example is shown in Figure S1) for studying the
properties of the SXL proteins to bind to RNA ligands carrying either single (grey) or double (black) poly(U) sequences. The fraction of bound RNA was
quantified and plotted as a function of SXL protein concentration. Solid lines correspond to the best fit of Hill eqn.1 to the binding data obtained
from titration of RNAs, with the best-fit parameters written in Table 1. ‘‘F’’ is defined by Eqn. 1, which is described in Materials and Methods.
doi:10.1371/journal.pone.0065171.g002
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a second PCR (upper gel in Figure 3B). Only the lanes
corresponding to the Drosophila protein (SXM) and its chimera
with the N-terminal of Sciara (SX17) presented the band (226 bp)
corresponding to the female-specific splicing of tra primary
transcript. Since the males have only the non-sex-specific tra
mRNA isoform, the detection of the induced female-spliced
isoform by the transgenic SXL proteins could be hampered by the
preferential amplification of the male-specific isoform, which is
more abundant. We then perform a third PCR but this time the
extension time was shortened to 7 seconds so as to favour the
amplification of the female-specific (226 bp) against the non-sex-
specific (401 bp) band. The results are shown in Figure 3B (lower
gel). The similar intensity of the female band for SX17 and SXM
suggests that the Drosophila SXL protein with the N-terminal
domain of Sciara (chimera SX17) appeared to be as efficient as the
own Drosophila SXL protein (SXM) in controlling the female-
specific splicing of tra pre-mRNA. However, the Drosophila SXL
protein with the C-terminal domain of Sciara (chimera SX64) was
less efficient as indicated by the lower intensity of the 226 bp band.
The normal Sciara SXL protein (SXS) and the Sciara SXL protein
with the C-terminal domain of Drosophila (chimera SX28) had no
effect on tra pre-mRNA splicing regulation, whereas the Sciara
SXL protein with the N-terminal domain of Drosophila (chimera
SX35) had a certain effect though very little as revealed by the
lower intensity of the female band. For all transgenes, PCR
reactions with RNA samples were performed to guarantee there
was no contamination with genomic DNA (negative controls of
PCR reactions).
The outcome of transgenic SXL proteins on dosage compen-
sation was studied through their effect on the splicing regulation of
endogenous msl-2 pre-mRNA. All the transgenic SXL proteins,
including the own Drosophila protein, failed to induce the female-
specific splicing of msl-2 primary transcript. Following the
reasoning for analysing the tra pre-mRNA splicing, a second and
a third PCRs were performed without any positive result, even for
the normal Drosophila SXL protein (data not shown). Except for the
Sciara (SXS) and its chimera with the C-terminal domain of
Drosophila (SX28), these were unexpected results since the rest of
the transgenic SXL proteins caused male-specific lethality, as
previously shown. Particularly surprising was the negative result of
the own Drosophila SXL protein (SXM). Nevertheless, it could be
argued that the transgenic proteins did not affect msl-2 pre-mRNA
splicing regulation but the translation of the mature msl-2 mRNA,
since SXL controls dosage compensation by regulating msl-2
expression not only at the splicing but also at the translational level
of msl-2 mRNA. Hence, the presence of the MSL2 protein was
analysed. The results of the Western-blot with total proteins
extracts from the transgenic males probed with the affinity-purified
antibody to D. melanogaster MSL-2 protein [14] showed that this
was present in all transgenic males, at similar amounts to that
found in wild type males (data not shown).
The cases where the transgenic Sxl genes showed no effect on
Sxl, tra and msl-2 cannot be attributed to a failure in their
expression since RT-PCR assays of total RNA from the transgenic
males demonstrated the expression of the transgenes. Further-
more, the Western-blot with total proteins extracts from the
transgenic Sxs, Sx28 and Sx35 males probed with the affinity-
purified antibody to S. ocellaris SXL protein [36] showed the
presence of the transgenic proteins (Figure S3). The antibody does
not recognise Drosophila SXL protein [36]. Notwithstanding, the
occurrence of transgenic SXM, SX17 and SX64 proteins was
verified by their effect on Sxl and tra pre-mRNA splicing regulation
(Figure 3A,B).T
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Discussion
It is common that the arising of proteins with new functions
being preceded by duplication of the gene encoding the original
protein, followed by modification of one of the duplicated copies
that acquires a new function (neo-functionalisation). The SXL
protein that controls sex determination and dosage compensation
in Drosophila is an example [43,44]. The duplication event that
gave rise to Sxl and its paralog sister-of-Sex-lethal (ssx) occurred in the
Brachycera (to which Drosophila belongs) after the Nematocera (to
which Sciara belongs) branched off and before the Drosophila species
split [43]. It seems, however, that the molecular evolution of Sxl
and ssx did not follow the classical evolutionary pattern of
duplication and posterior neo-functionalization, but a sub-
functionalization model [44,46].
The domains composing proteins can be defined from the
structural, functional or evolutionary point of view (reviewed in
[47]). The first refers to protein segments that behave as folding
(structural) entities; the second stands for the activity given to the
protein; and the third makes reference to the degree of
evolutionary conservation. The analyses in vitro and in vivo of
different Drosophila SXL-truncated protein constructs determined
that Drosophila SXL contains three well-defined domains (see
Introduction). The comparison of SXL proteins from different
insects, belonging to different genera and families, has revealed
that its spatial organisation is conserved, with the RBD domains in
the central region, showing the highest degree of conservation,
whereas the N- and C-terminal domains showing significant
variation [33,34,37,43]. This high degree of conservation of RBDs
at the amino acid level is not reflected at the nucleotide level,
indicating that the great majority of nucleotide changes are
synonymous, and that purifying selection is acting on the RBD
domains [37,46]. These results led to the proposal that the changes
experienced by the Drosophila SXL protein during its evolution
might be mainly located in its terminal domains [33,34,37].
To address the question about the molecular evolution of
Drosophila SXL protein, Drosophila-Sciara chimeric SXL proteins
were synthesised by inter-changing their N- and C-terminal
Figure 3. Effect of the SXL proteins on the sex-specific splicing of endogenous Sxl (A) and tra pre-mRNAS (B) in males carrying a null
allele of Sxl. The conditions and primers for the RT-PCRs are described in Materials and Methods. The constitution of the SXL proteins is described in
the Tables; and ‘‘melano m’’ and ‘‘melano f’’ stand for Drosophila wild type male and female, respectively. The genotypes of the males were: Sxm
stands for males ywSxlf1ct6/Y; arm-Gal4,w+/+; Sxm/Tub-Gal80ts; Sxs stands for males ywSxlf1ct6/Y; arm-Gal4,w+/+; Sxs/Tub-Gal80ts; Sx17 stands for males
ywSxlf1ct6/Y; arm-Gal4,w+/+; Sx17/Tub-Gal80ts; Sx64 stands for males ywSxlf1ct6/Y; arm-Gal4,w+/Sx64; Tub-Gal80ts/+; Sx35 stands for males ywSxlf1ct6/Y;
arm-Gal4,w+/Sx35; Tub-Gal80ts/+; and Sx28 stands for males ywSxlf1ct6/Y; arm-Gal4,w+/Sx28; Tub-Gal80ts/+. These males were produced by crossing
females ywSxlf1ct6/Y; arm-Gal4,w+/CyO,Cy; Tub-Gal80ts/MKRS,Sb with males yw/Y; Sxm/MKRS,Sb; males yw/Y; Sxs/MKRS,Sb; males yw/Y; Sx17/MKRS,Sb;
males yw/Y; Sx64/CyO,Cy; males yw/Y; Sx35/CyO,Cy; and males yw/Y; Sx28/CyO,Cy.
doi:10.1371/journal.pone.0065171.g003
Molecular Evolution of the Sex-Lethal Protein
PLOS ONE | www.plosone.org 8 June 2013 | Volume 8 | Issue 6 | e65171
domains and their functionality in Drosophila were tested. It is
reasonable to assume that Sciara SXL behaves as a general splicing
factor, representing the non-sex-specific function of SXL protein
in the non-drosophilids and so the function of the ancient SXL
from which the extant Drosophila SXL protein evolved [36,37] (see
Introduction). However, the Drosophila SXL behaves a sex-specific
splicing factor, having three functions: (1) auto-regulation, which is
manifested by its requirement to regulate its expression during
development and adult life through its involvement in the female-
splicing regulation of its own primary transcript; (2) control of sex
determination by regulating the female-specific splicing of tra pre-
mRNA to produce functional TRA protein only in females; and (3)
control of dosage compensation through splicing and translation
regulation of msl-2 pre-mRNA and mRNA, respectively. Two
questions were addressed. Did the Drosophila SXL protein have
affected their functions when their N- and C-terminal domains
were replaced by the corresponding ones of Sciara? Alternatively,
did the Sciara SXL protein acquire Drosophila SXL sex-specific
functions when the N- and C-terminal domains of this replace
those of Sciara? The criteria used to test the functionality of the
Drosophila-Sciara chimeric SXL proteins were the following:
1. The auto-regulatory function was studied by comparing the
specific lethality of males with and without an endogenous Sxl+
copy, and by analysing in males the splicing of Sxl pre-mRNA
from an endogenous Sxl null allele.
2. The sex-determination function could not be checked by
monitoring the ability of chimeras to impose the female
development to males carrying a null allele of Sxl. Notwith-
standing, the sex-determination function was checked by
monitoring the effect of the chimeras on the female-specific
splicing of endogenous tra pre-mRNA in males carrying an
endogenous Sxl null allele.
3. The dosage compensation function was examined by analysing
the specific lethality of males without an endogenous Sxl+ copy.
The viability of females was never compromised by the
expression of transgenic SXL proteins so that the male-specific
lethality is a bona fide indicator of dosage compensation upset.
The study of these chimeras on the splicing and translation of
msl-2 pre-mRNA and mature mRNA, respectively, failed to
detect any effect. This was unexpected for those cases where
male-specific lethality was observed, especially in the case of
the own Drosophila SXL protein. We have no reason for this
result except to say that because this analysis was done on adult
males, dosage compensation might not be so critical for the
function of the adult somatic tissues as it is during development.
It has been shown that dosage compensation exists in the germ
line of Drosophila adults [48,49,50], although it has been
claimed the opposite [51], but it appears that genes different
from the msl genes implement this dosage compensation
[52,53,54].
Since the Drosophila SXL protein exerts its functions through its
capacity to bind to RNA, the biophysical properties of the normal
Drosophila and Sciara SXL proteins as well as their chimeras were
firstly tested. To this respect, their binding capacity to single and
double poly(U) sites of Drosophila were studied. The results on this
in vitro analysis are summarised. Firstly, although the binding
capacity of both Drosophila and Sciara RNA-binding domains,
without the N- and C-terminal domains, was similar, the whole
SXL protein of Drosophila showed a binding ability higher than that
of Sciara in the case of a single binding site, but both proteins
presented a similar affinity in the case of a double binding-site.
Secondly, the binding capacity of the Drosophila SXL protein
decreased when that of Sciara replaces either its amino- or its
carboxyl-terminal domain, whereas the binding capacity of the
Sciara SXL protein improved when that of Drosophila replaces
either its amino- or its carboxyl-terminal domain, although this
improvement did not reach the capacity shown by the own
Drosophila SXL protein. Finally, whereas the SXL protein of
Drosophila showed co-operative properties, that of Sciara did not.
Moreover, the co-operation exhibited by Drosophila SXL protein is
impaired when either its N- or C-terminal domains were replaced
by the corresponding ones of Sciara SXL protein. Similarly, this
protein did not acquire co-operative properties when its N- or C-
terminal domains were replaced by those of Drosophila SXL
protein. Collectively, these results indicate that the binding
capacity of SXL and its co-operative ability is a property of the
whole protein rather than due to a specific domain.
The results of in vivo analyses regarding the function of the
chimeric SXL proteins are summarised in Table 3. The normal
Sciara SXL protein (SXS) and that carrying the C-terminal domain
of Drosophila SXL (chimera SX28) did not show any of the
functions of Drosophila SXL protein. The other three chimeric
proteins presented different degrees of the auto-regulatory, the sex
determination and the dosage compensation functions. It has been
described that the N-terminal domain of Drosophila SXL protein is
involved in protein-protein interactions (SXL multimerisation) and
endows to SXL with co-operative function, which is absolutely
required for proper control of Sxl pre-mRNA alternative splicing
[18–21]. The Drosophila SXL protein showed auto-regulatory
function when its N-terminal domain was replaced by the
corresponding one of Sciara (chimera SX17), and a lower auto-
regulatory function if the C-terminal domain is the one that was
replaced (chimera SX64). The Sciara SXL protein gained some
auto-regulatory function when the corresponding ones of Drosophila
replaced its N-terminal (chimera SX35) but not its C-terminal
(chimera SX28) domain. In addition these chimeras had no co-
operative properties. These results suggest that co-operation per se
is not absolutely necessary for Sxl auto-regulation but it matters the
large-scale structure of the SXL protein, with the N-terminal
domain playing a leading role. In this context, it is worth
mentioning that the early SXL protein shows auto-regulatory
function although the beginning of its N-terminus domain differs
in amino acid sequence with respect to the sequence in the late
SXL protein [55]. With respect to the sex determination function,
the chimeras paralleled their behaviour on Sxl auto-regulation.
The Drosophila SXL protein lost its dosage compensation
function when its entire N-terminal region was replaced by the
complete one of Sciara (chimera SX17). This result seems to be in
contradiction with the reported result that the N-terminal domain
of Drosophila SXL protein is not required for preventing msl-2
expression [10,26] and that the two SXL RBD domains by
themselves are able to control in vitro msl-2 mRNA translation [26].
This discrepancy might be explained by the different SXL protein
constructs used. Whereas in this work a complete Drosophila-Sciara
chimeric protein was employed, Gebauer et al. [26] used a
truncated Drosophila SXL protein lacking the first 93 and the last
32 amino acids of the N- and C-terminal domains, respectively;
and Yanowitz et al. [10] used a truncated Drosophila SXL protein
lacking the first 38 amino acids of the N-terminal domain. Hence,
the truncated Drosophila constructs and the whole Drosophila-Sciara
chimeric protein are likely to have affected their global structure in
a different way, what might determine their dissimilar function on
dosage compensation. To this respect, the Sciara SXL protein
gained some dosage compensation function when its N-terminal
(chimera SX35) but not its C-terminal (chimera SX28) domain
was replaced by the corresponding ones of Drosophila.
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In general terms, there is agreement between the in vitro and the
in vivo results, although the in vitro results cannot be straightforward
extrapolated to the function of SXL in vivo. The results generated
by in vitro analysis gave us information about the affinity and co-
operation of SXL proteins in a scenario where the protein and the
ligand (RNA sequence) were the only actors, whereas in the in vivo
scenario other factors modulating the physical properties of the
SXL and then its function came into play. Actually, it has been
shown that the Drosophila SXL protein requires its interaction with
other proteins encoded by the genes snf [56,57], fl(2)d [58,59] and
vir [60,61] to exert its function. Nevertheless, all the results
presented here led us to propose that the functional properties of
the extant Drosophila SXL protein depend on its global structure
rather than on a specific domain; that is, the binding capacity of
SXL, which is exerted through its two RNA binding domains, and
SXL multimerisation, which seems to be implemented by the N-
terminal domain, require the carboxyl-terminal domain. Further-
more, it is proposed here that the RNA-binding capacity of the
Drosophila SXL protein might be a property already present in the
ancestral SXL protein of the insects from which the dipterans
evolved and that the modifications, mainly in the N- and C-
terminal domains, that occurred in the SXL protein during its
evolution within the drosophilid lineage represented co-evolution-
ary changes that determine the appropriate folding of SXL to
carry out its sex-specific functions.
This assertion receives further support from the results
regarding the effect of ssx null mutations on Drosophila: the lack
of ssx function does affect neither the viability nor the sexual
development of both males and females; that is, ssx does not have
the sex-specific functions shown by Sxl [44]. Moreover, the
comparison of SSX with Drosophila SXL ([43] and our own data)
and Sciara SXL (our own data) revealed that the RBDs domains
are also the best conserved (79% and 70% for Drosophila and Sciara,
respectively), followed by the C-terminal domain (45% and 40%
for Drosophila and Sciara, respectively), whereas the N-terminal
domain showed very low similarity (8% and 5% for Drosophila and
Sciara, respectively).
Materials and Methods
Flies and Crosses
Drosophila flies were cultured on standard food. For the
description of the mutant alleles and GAL4 constructs see Lindsley
and Zimm [62] and FlyBase.
Molecular Analyses
Total RNA extracts from frozen adults were prepared using the
Trizol-reagent kit (Invitrogen) following the manufacturer’s
instructions. Five micrograms of total RNA from each sample
were reversed transcribed with Superscript III (Invitrogen)
following the manufacturer’s instructions. Reverse transcription
reactions were performed with primer Sxlmel6 (59CCAGCGA-
CAATCCGCAGAG39) located in exon 5 of D. melanogaster Sxl for
splicing analysis of the endogenous Drosophila Sxl gene; with primer
tramel2 (59TGCTGCGACTTCGGCTATG39) located in exon 2
of D. melanogaster tra gene for splicing analysis of the endogenous
Drosophila tra gene, and with primer msl2mel3 (59GTCACCTT-
CAAGTATGCCGTC39) located in exon 1 of D. melanogaster msl-2
gene for splicing analysis of the Drosophila msl-2 gene. Two percent
of the synthesised cDNA was amplified by PCR. For splicing
analysis of the endogenous Drosophila Sxl pre-mRNA, the primers
used in the PCR were Sxlmel5 (59ACCGAAACTCACCTTC-
GATC39) located in exon2 and primer Sxlmel3 (59CCGGATGG-
CAGAGAATGGGAC39) located in exon 4. The expected size of
the amplicon is 384 bp for male and 190 bp for female. For
splicing analysis of the Drosophila tra pre-mRNA, the primers used
in the PCR were tramel1 (59CAAGGTGCAAGCCGAGTAC39)
located in 59 UTR and primer tramel5 (59AACCTCGTCTG-
CAAAGTACGG39) located in exon 2 upstream to tramel2. The
expected size of the amplicon is 401 bp for male and 226 bp for
female. For splicing analysis of the Drosophila msl-2 pre-mRNA, the
primers used in the PCR were msl2mel1 (59CA-
CACTGGCTTCGCTCAGC39) and primer msl2mel2
(59CAGCCCAAAAGTGAGACTCC39) located in 59 UTR
flanking the sex-specifically spliced intron. The expected size of
the amplicon is 256 bp for male and 389 bp for female. The
amplicons were analysed by electrophoresis in 2% agarose gels. In
all cases, PCR reactions with RNA samples were performed to
guarantee there was no contamination with genomic DNA
(negative controls of PCR reactions).
Construction and Purification of SXL Proteins
Figure S4 shows the location of all the primers used in the
construction of the chimeric SXL proteins.
The GST expression system was used to produce the SXL
fusion proteins following Smith and Johnson [63] with minor
changes. To generate the GST-SXS fusion, the whole ORF of
Sciara Sxl was amplified from cDNA with primers Gex1
(59CGGGGATCCAATCAGAGTGAGTGTCG39) and Gex2
(59GCAAAGCTTATTAGCTTTCATCTCAATA39) containing
a restriction site for BamHI and HindIII, respectively. The
amplicon was cloned in pGEMT-easy (Promega) and sequenced.
The DNA of the pGEMT-easy vector containing the Sciara Sxl ORF
was cut with BamHI and HindIII and the fragment was ligated in
frame into the pGex-B vector using the T4 DNA ligase (Roche).
Table 3. Function of the transgenic Drosophila-Sciara chimeric SXL proteins.
SXL protein N-terminal domain
RNA-binding
domains C-terminal domain
Auto-regulatory
function
Sex determination
function
Dosage compensation
function
SXM Drosophila Drosophila Drosophila YES (+++) YES (+++) YES (+++)
SXS Sciara Sciara Sciara NO NO NO
SX17 Sciara Drosophila Drosophila YES (+++) YES (+++) NO
SX64 Drosophila Drosophila Sciara YES (++) YES (++) YES (+)
SX35 Drosophila Sciara Sciara YES (+) YES (+) YES (++)
SX28 Sciara Sciara Drosophila NO NO NO
The degree of functionality of SXL proteins is qualitatively indicated by the number of ‘‘+’’.
doi:10.1371/journal.pone.0065171.t003
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The GST-SXM fusion construct was obtained from Dr. J.
Valca´rcel [8].
To generate the GST-SX17 fusion, the sequence of the Sciara
Sxl ORF encoding the N-terminal domain of SXL was amplified
from cDNA with primers Nter1s (59CGGGATCCAATGTACAA-
TAAGAATGGGTATC39) and Nter2s (59TCTAGAGCCAGCA-
CAGCCAGTTAG39) containing a restriction site for BamHI and
XbaI, respectively. The fragment of the Drosophila Sxl ORF
encoding the two RNA-binding domains plus the C-terminal
domain was amplified with primers Rbd1m (59TCTAGAAC-
CAACCTGATTGTCAACTAC39) and Cter2m
(59GCAAAGCTTTCAGATAAACTTTTTAGCATG39) con-
taining a restriction site for XbaI and HindIII, respectively. To
generate the GST-SX64 fusion, the sequence of the Sciara Sxl ORF
encoding the C-terminal domain of SXL was amplified from
cDNA with primers Cter1s (59CTCGAGGGCAAACAGAAAGC-
GACC39) and Cter2s (59GCAAAGCTTTCAATATGGACT-
TATGTTCTG39) containing a restriction site for XhoI and
HindIII, respectively. The fragment of the Drosophila Sxl ORF
encoding the N-terminal domain plus the two RNA-binding
domains was amplified with primers Nter1m (59CGGGATCC-
TATGTACGGCAACAATAATCC39) and Rbd2m
(59CTCGAGCTCAGCCAACCGGACG39) containing a restric-
tion site for BamHI and XhoI, respectively. To generate the GST-
SX35 fusion, the sequence of the Drosophila Sxl ORF encoding the
N-terminal fragment of SXL was amplified from cDNA with
primers Nter1m (above) and Nter2m (59TCTAGATGCCCGAG-
GATCGTTCATG39) containing a restriction site for BamHI and
XbaI, respectively. The fragment of the Sciara Sxl ORF encoding
the two RNA-binding domains plus the C-terminal domain was
amplified with primers Rbd1s (59TCTAGAACCAATT-
TAATTGTTAACTATTTAC39) and Cter2s (above) containing a
restriction site for XbaI and HindIII, respectively. To generate the
GST-SX28 fusion, the sequence of the Drosophila Sxl ORF
encoding the C-terminal fragment of SXL was amplified from
cDNA with primers Cter1m (59CTCGAGGGCAAGGC-
GAAGGCGGC39) and Cter2m (above) containing a restriction
site for XhoI and HindIII, respectively. The fragment of the Sciara
Sxl ORF encoding the N-terminal domain plus the two RNA-
binding domains was amplified with primers Nter1s (above) and
Rbd2s (59CTCGAGTTCGGCAACGCGTACGC39) containing a
restriction site for BamHI and XhoI, respectively. All the
amplicons were cloned in pGEMT-easy (Promega) and sequenced.
The DNA of pGEMT-easy vectors was cut with the corresponding
restriction enzymes and the fragments were ligated in frame into
the pGex-B vector using the T4 DNA ligase (Roche). To generate
the GST-RBDs-mel fusion, the sequence of Drosophila Sxl ORF
encoding the two RNA-binding domains plus the linker was
amplified with primers D1 (59ATGAAGGATCCTCGGG-
CAAGCA39) and D2 (59GGAACCAAGCTTATCTACGACA-
TAAAG39) containing a restriction site for BamHI and HindIII,
respectively. To generate the GST-RBDs-sci fusion, the sequence
of Sciara Sxl ORF encoding the two RNA-binding domains plus
the linker was amplified with primers S1 (59CTGGGATCC-
CAGCGGCACC39) and S2 (59TCATGTTCAAGCTT-
GAATTTTAAAATTG39) containing a restriction site for BamHI
and HindIII, respectively. The amplicons were cloned in pGEMT-
easy (Promega) and sequenced. The DNA of the pGEMT-easy
vectors was cut with BamHI and HindIII and the fragments were
ligated in frame into the pGex-A vector using the T4 DNA ligase
(Roche). All the positive clones were sequenced to ascertain correct
orientation.
Construction of UAS::Chimeric-Sxl-cDNA Transgenes
For the construction of the transgenes, the whole ORF of the
corresponding chimeric SXL proteins (SX17, SX64, SX35 and
SX28) plus the Drosophila (SXM) and Sciara (SXS) SXL proteins
were amplified using as template the GST-SXL fusion construc-
tions described above. The primers used for the Sxm transgene
were pUASSxl1m (59GAAGATCTATATGTACGGCAACAA-
TAATCC39) and pUASSxl2m (59GGGGTACCTTCAGA-
TAAACTTTTTAGCATCG39) containing the restriction sites
for BglII and KpnI, respectively. The primers used for the Sxs
transgene were pUASSxl1s (59GAAGATCTAATGTACAATAA-
GAATGGGTATC39) and pUASSxl2s (59GGGGTACCCTCAA-
TATGGACTTATGTTCTG39) containing the restriction sites
for BglII and KpnI, respectively. The primers used for the Sx17
and Sx28 transgenes were pUASSxl1s and pUASSxl2m, and for the
Sx35 and Sx64 transgenes were pUASSxl1m and pUASSxl2s,
described above. The amplicons were cloned in pGEMT-easy
(Promega) and sequenced. The DNA of the pGEMT-easy vectors
was cut with BglII and KpnI and the fragments were ligated into
pUAST vector. The microinjections for generating the transgenic
D. melanogaster lines were performed by Genetic Services (Sudbury,
MA, USA). Standard genetic crosses determined the chromosomal
location of the transgenes. To ascertain that each transgenic line
was carrying the correct transgene, RT-PCR analysis was
performed and the amplicons corresponding to the whole
transgenes were cloned and sequenced.
Preparation of RNA Substrates for Binding Assays
The poly(U) sequence 59ACAUAUUUUUUUUCACAGC39
located at the 59 end of the male-specific exon 3 of D. melanogaster
was used as a substrate for RNA-binding assays. The RNA ligand
was prepared as follows. An oligonucleotide with that poly(U)
sequence preceded by the T7 promoter sequence was synthesised.
This was used in in vitro transcription using T7 RNA polymerase
and the Fluorescin RNA labelling mix kit (Roche). The same
procedure was used for preparing the RNA substrate in the RNA-
binding assays for testing cooperative capacity of the chimeric
SXL proteins, except that in this case the RNA ligand contained
two contiguous poly(U) sequences (59CATGAT-
TAUUUUUUUUUAUUUUUUUUCGGTGA39) located in in-
tron 3 of D. melanogaster Sxl pre-mRNA and known to bind Sxl in a
co-operative manner [20].
In vitro transcribed RNA was precipitated by adding 0,1 volume
of NaAc 3 mM and 2.5 volumes of absolute ethanol, and
resuspended in sterile RNase-free water. The concentration was
measured in Nanodrop.
RNA Binding Assays (Electrophoretic Mobility Shift Assay,
EMSA)
The SXL proteins were mixed with yeast tRNA (3 mg) in the
binding buffer (20 mM Hepes at pH 8.0, 0,1 M KCl, 0,5 mM
EDTA, 1 mM DTT, 0,05% NP40 and 20% glycerol) during 5
minutes on ice. The RNA substrate (2,6 mg for one single- and
2 mg for double-binding sites) is then added and incubated at room
temperature for 10 minutes. The samples were loaded and
resolved on a 5% non-denaturating polyacrylamide gel (60:1
acrylamide to bis-acrylamide) in 0,256TBE. A 15 minutes pre-
run at 50 Volts was performed before loading the samples and the
run lasted 1 hour at 250 Volts. The gel was analysed by using UV
light Gel-Doc.
The binding of SXL proteins to RNAs containing one or two
poly(U) sequences as measured by EMSA assays was well
described by the empirical Hill function [64]: F= (C/C50)
n/(1+
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(C/C50)
n) (eqn. 1), where F is the fraction of complex at each point
in the binding titration, C is the protein concentration, C50 is the
protein concentration at half binding saturation, and n is a Hill
coefficient. In the absence of a detailed molecular binding
mechanism, this analysis allows estimating an apparent value for
the dissociation constant, Kd (Kd = 1/C50, for n = 1) and to
compare the binding properties of the different protein variants
used in this study. A Matlab model script was written for fitting
this model to the binding data.
Western Blots
Samples of total proteins from adult transgenic males were
prepared by homogenisation in STE buffer (10 mM Tris, pH 8.0,
150 mM NaCl, 1 mM EDTA) containing protease inhibitors
complete Mini, EDTA free kit (Roche). SDS-polyacrylamide gels
(8% for MSL2 protein or 12% for SXL protein) [65] were blotted
onto nitrocellulose [66], blocked with 5% BSA, 10% non-fat dried
milk and 0.05% Tween-20 in PBS, and hybridised with anti-
MSL2 (1:2000) [14] or anti-SXL (1:1000), a polyclonal antibody
against the S. ocellaris SXL protein [36], overnight at 4uC. After
washing in 0.05% Tween-20 in PBS (TPBS), filters was incubated
with the secondary antibody (goat anti-rabbit IgG-HRP conjugat-
ed (1:2000) (Santa Cruz Biotechnology) for 1 h at room
temperature. Filters were washed in TPBS and developed with
the ECL Western blotting analysis kit (Amersham Pharmacia
Biotech).
Supporting Information
Figure S1 Examples of binding of SXL proteins to one single
SXL-binding site. The amount of SXL proteins and RNA
substrate is indicated in mg above each lane.
(TIFF)
Figure S2 EMSA (A) and Western-blot (B) for the interaction
between the Sciara SXL (SXS) protein and the Drosophila SXL-
binding site. (A) The RNA sequence is described in Materials and
Methods. Lanes 1, 2, 3, 7, 8 and 9 corresponded to 3 mg of SXS
protein used in the reaction, whereas lanes 4, 5, 6, 10, 11 and 12
corresponded to 0,7 mg of SXS protein used in the reaction. The
arrow in indicates the wells of the gel. (B) Western-blot to
demonstrate to existence of SXS protein retained in the wells of
the EMSA shown in (A). The material retained in the wells was
extracted and used for the Western–blot. Lane 1 corresponds to
the material retained in the wells of lanes 1, 2 and 3; lane 2
corresponds to the material retained in the wells of lanes 7, 8 and
9; lane 3 corresponds to the material retained in the wells of lanes
4, 5 and 6, and lane 4 corresponds to the material retained in the
wells of lanes 10, 11 and 12. C stands for the SXS protein alone
and used as control. The Western-blot was hybridised with the
serum against the Sciara SXL protein [36].
(TIFF)
Figure S3 Western-blot hybridised with serum against the Sciara
SXL protein [36] showing the expression of the transgenic SXL
proteins. The antibody does not recognise Drosophila SXL protein
[36]. See text for details.
(TIFF)
Figure S4 Scheme showing the Drosophila-Sciara chimeric SXL
proteins, where the location of the primers used for their
construction is indicated. The sequences of the primers and the
added sequences for the restriction enzymes are described in
Materials and Methods. N-mel, RBD-mel and C-mel stand,
respectively, for the amino-terminal domain, the two RNA-
binding domains and the carboxyl-terminal domain of Drosophila
SXL. N-sci, RBD-sci and C-sci stand, respectively, for the amino-
terminal domain, the two RNA-binding domains and the
carboxyl-terminal domain of Sciara SXL.
(TIFF)
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